Finance

The oil and gas producer has struggled to convince investors about its prospects for years, but that could change.

Falling sales and profits sent investors scurrying for the checkout aisle.

The company fell just shy of analyst estimates in its latest reported quarter.

CYD earnings call for the period ending June 30, 2021.

Earnings weren’t as strong as investors were hoping for, but there are some silver linings.

The small-cap fintech is now up roughly 83% year to date.

It’s a case of “buy the rumor, sell the news.”

A disappointing earnings report pushed down shares of the over-the-counter medicine seller.

A hot economy and high inflation have almost every Dow Jones stock gaining today, pushing the index to a new all-time high.

LAND earnings call for the period ending June 30, 2021.

It’s telling how investors have stopped jumping into budding rebounds from the stock, and instead are now using them to make exits.

Compelling clinical-trial data that could validate the company’s unique approach to new drug development inspired a slew of analyst upgrades.

Investors look like they’re finally starting to ask valuation questions now that growth isn’t so easy to come by.

DAR earnings call for the period ending July 3, 2021.

Cassava believes that a mutating protein, Filamin A, is a major culprit behind Alzheimer’s disease. The company’s drug, simufilam, aims to fix this mutation and restore its proper form and function.

Fewer people are watching their weight during the pandemic.

The car-sharing marketplace reported a huge loss despite record revenue.

WEN earnings call for the period ending July 4, 2021.

The company’s latest earnings results didn’t show enough improvement in profitability to excite investors.

Sorry, seniors — looks like those benefits might continue to let you down.